
Opinion|Videos|December 8, 2023
Navigating Endocrine Resistance in the Treatment of ER+/HER2- Metastatic Breast Cancer
Author(s)Hope S. Rugo, MD
Current treatment landscape in ER+/HER2- metastatic breast cancer and unmet needs in overcoming treatment resistance.
Episodes in this series








































